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Validity, reliability and minimal detectable change of the Balance 1 
Evaluation Systems Test (BESTest), Mini-BESTest and Brief-BESTest 2 
in patients with end-stage renal disease 3 
Purpose: This study determined the validity, test-retest reliability and minimal detectable 4 
change of the Balance Evaluation Systems Test (BESTest), Mini-BESTest and Brief-5 
BESTest in patients with end-stage renal disease. 6 
Methods: A cross-sectional study with 74 patients with end-stage renal disease (male 7 
66.2%; 63.9±15.1 years old) was conducted. Participants were asked to report the 8 
number of falls during the previous 12 months and to complete the Activity-specific 9 
Balance Confidence Scale. The BESTest was administered, and the Mini-BESTest and 10 
Brief-BESTest scores were computed based on the BESTest performance. Validity was 11 
assessed by correlating balance tests with each other and with the Activity-specific 12 
Balance Confidence Scale. Test-retest relative reliability and agreement were explored 13 
with the Intraclass correlation coefficient equation (2,1) and the Bland and Altman 14 
method. Minimal detectable changes at the 95% confidence level were established. 15 
Results: Balance test scores were significantly correlated with each other (spearman’s 16 
correlation=0.89-0.92) and with the Activity-specific Balance Confidence Scale 17 
(spearman’s correlation=0.49-0.59). Balance tests presented high test-retest reliability 18 
(Intraclass correlation coefficient=0.84-0.94), with no evidence of bias. Minimal 19 
detectable change values were 10.8 (expressed as a percentage 13.5%), 5.3 (23.7%) and 20 
5.6 (34%) points for the BESTest, Mini-BESTest and Brief-BESTest, respectively. 21 
Conclusions: All tests are valid and reliable to assess balance in patients with end-stage 22 
renal disease. Nevertheless, based on the minimal detectable changes found, BESTest and 23 
Mini-BESTest may be the most recommended tests for this specific population. 24 
 25 
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Introduction 1 
Chronic kidney disease affects 11-13% of the population worldwide,[1] being an 2 
important public health issue with high socioeconomic burden. This long term and 3 
progressive condition is associated with fatigue, muscle weakness and reduced physical 4 
activity.[2, 3] As a result, patients with chronic kidney disease, and particularly with end 5 
stage renal disease (ESRD) may experience difficulties in performing activities of daily 6 
living that require balance control and be at high risk of falling.[4] 7 
Recent literature indicates that 17.2% to 47% of patients with ESRD fall at least once 8 
during a 3-12 month period.[5, 6] Thus, valid, reliable and clinically feasible tests for 9 
comprehensive assessment of balance impairments are needed to screen balance 10 
impairments, inform the design and evaluate the impact of optimal interventions for fall 11 
reduction. 12 
A number of balance tests have been described in the literature.[7, 8] The Balance 13 
Evaluation Systems Test (BESTest) was developed to assess balance comprehensively. 14 
It assesses functioning of six balance control systems[9] and has been one of the most 15 
commonly used test in patients with chronic diseases, such as cancer,[10] Parkinson’s 16 
disease[11] and chronic obstructive pulmonary disease.[12] However, while the 17 
clinimetric properties of this test, such as validity, test-retest reliability and minimal 18 
detectable change, have been established in several specific populations,[13, 14, 15] they 19 
have not yet been investigated in patients with ESRD. 20 
Due to the time required to complete the BESTest (approximately 20-30 minutes),[14] 21 
shortened versions were developed, the Mini-BESTest[16] and the Brief-BESTest.[14] 22 
The Mini-BESTest includes important aspects of dynamic balance control, reflecting 23 
balance challenges during activities of daily living (administration takes approximately 24 
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15 minutes).[16] In contrast, the Brief BESTest contains items that assess all balance 1 
systems outlined by the original BESTest, requires less administration time 2 
(approximately 10 minutes) and less equipment, which can favor its clinical use.[14] 3 
These shortened versions have also gained interest to assess balance in patients with 4 
Parkinson’s disease,[17] multiple sclerosis,[14] and balance disorders.[18] Nevertheless, 5 
to the authors’ knowledge, neither the Mini-BESTest nor the Brief-BESTest have been 6 
applied, or their clinimetric properties studied, in patients with ESRD. Determining the 7 
clinimetric properties and associated measurement error of these tests is fundamental to 8 
decide whether they are appropriate to detect balance impairments in patients with 9 
ESRD[19] and can be used in the clinical management of these patients. 10 
Therefore, the purpose of this study was to determine the validity, test-retest reliability 11 
and the minimal detectable change of the BESTest, Mini-BESTest and the Brief-BESTest 12 
in patients with ESRD. 13 
 14 
Methods 
15 
Study design and ethics 16 
A cross-sectional study was conducted from December 2013 to June 2014 in the central 17 
region of Portugal. Ethical approval was obtained from the Ethics Committee of the 18 
Research Unit of Health Sciences at the School of Nursing in Coimbra (P185-10/2013). 19 
This study is reported following the COnsensus‐based Standards for the selection of 20 
health Measurement INstruments,[20] the STrengthening the Reporting of OBservational 21 
studies in Epidemiology statement[21] and the guidelines for reliability and agreement 22 
studies.[19] 23 
Participants 24 
6 
 
Three renal dialysis centers participated and clinicians in each center identified eligible 1 
patients according to the following criteria: (i) had ESRD; ii) were receiving adequate 2 
hemodialysis or peritoneal dialysis for at least 3 months (Kt/V >1.2) and iii) were aged 3 
18 years or older. Patients were excluded if they i) had an hospitalization within the past 4 
3 months due to worsening of their health status; ii) had comorbidities that interfered with 5 
independent ambulation (e.g., hip fracture, lower limb amputation); iii) were taking 6 
medication that could cause dizziness or affect their balance  (e.g., psychotropic 7 
medications); iv) had severe respiratory (e.g., chronic obstructive pulmonary disease), 8 
neurological (e.g., Parkinson’s disease, multiple sclerosis), musculoskeletal (e.g., severe 9 
osteoarthritis) or psychiatric (e.g., psychosis, schizophrenia) disorders, that could 10 
interfere with the measurements. After screening, patients were contacted by the clinician, 11 
who explained the purpose of the study and asked about their willingness to participate. 12 
When patients agreed to participate, an appointment with the researchers was scheduled 13 
at their dialysis center. Written informed consent was obtained prior to data collection. 14 
Data collection procedures 15 
Two research physiotherapists collected the data. Socio-demographic (age and gender), 16 
anthropometric (height, weight, body mass index) and clinical (self-reported 17 
comorbidities - e.g., hypertension and hyperlipidemia) data were first collected. Patients 18 
were then provided with a clear definition of falls (an event when you find yourself 19 
unintentionally on the ground, floor or lower level)[22] and required to report their history 20 
of falls using two standardized questions (1. “Have you had any falls in the last 12 21 
months?” and, if yes, 2. “How many times did you fall down in the last 12 months?”).[23] 22 
The self-reported Activities-Specific Balance Confidence scale was used to assess 23 
balance confidence.[24] This scale quantifies an individual’s perceived ability to maintain 24 
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his/her balance under different circumstances, using a scale of 0% (no confidence) to 1 
100% (total confidence).[25] Finally, the BESTest was performed and participants were 2 
encouraged to rest, as needed. 3 
For each item of the BESTest, the physiotherapist read the instructions to the participant 4 
and performed the task. Then, the participant performed the task with close supervision. 5 
For test-retest reliability, participants were reassessed by 1 of the 2 physiotherapists 6 
within 5 days after session 1. Effort was made to keep all factors associated with the 7 
testing sessions consistent, specifically the time of day, area in which the tests were 8 
performed and use of a walking aid (if needed). The Mini-BESTest and Brief-BESTest 9 
scores were computed based on the performance of the BESTest tasks. A custom designed 10 
worksheet was used by the physiotherapists to simultaneously record the BESTest and 11 
the Mini-BESTest item scores. Brief-BESTest scores were extracted from the relevant 12 
subset of BESTest items. 13 
Balance Tests 14 
BESTest 15 
The BESTest contains 36 items organized into 6 subsections: biomechanical constraints, 16 
stability limits and verticality, anticipatory postural adjustments, postural responses to 17 
external perturbations, sensory orientation during stance and stability in gait.[9] Each 18 
item is scored from 0 (severe balance impairment) to 3 (no balance impairment) and the 19 
maximum possible total score is 108 points. BESTest has high test-retest reliability 20 
(Intraclass Correlation Coefficient - ICC=0.87-0.92) in individuals with and without 21 
balance disorders, in patients with Parkinson’s disease, in older cancer survivors and in 22 
patients with chronic obstructive pulmonary disease.[9, 10, 13, 15] 23 
Mini-BESTest 24 
8 
 
The Mini-BESTest includes 14 items from sections of the BESTest related to anticipatory 1 
postural adjustments, reactive postural responses, sensory orientation and stability in 2 
gait.[16] Two of the 14 items are scored bilaterally. Each item is scored from 0 (severe 3 
balance impairment) to 2 (no balance impairment) and the maximum possible score is 28 4 
points. Higher scores indicate better balance performance. High test-retest reliability 5 
(ICC=0.88-0.97) have also been found in patients with balance disorders, Parkinson’s 6 
disease, chronic stroke, chronic obstructive pulmonary disease and also in older cancer 7 
survivors.[10, 11, 15, 18, 26] 8 
Brief-BESTest 9 
The Brief-BESTest is a 6-item balance test, which contains 1 item from each of the 6 10 
subsections of the BESTest.[14] Two of the 6 items are scored bilaterally, resulting in an 11 
8-item balance test. Each item is scored from 0 (severe balance impairment) to 3 (no 12 
balance impairment) and the maximum possible score is 24 points. Higher scores indicate 13 
better balance performance.[14] It has also showed high test-retest (ICC=0.82-0.94) 14 
reliability in patients with chronic obstructive pulmonary disease,[15] older cancer 15 
survivors[10] and older adults living in the community.[27] 16 
Statistical analysis 17 
Descriptive statistics were used to describe the sample. A z-test was applied for normality 18 
test using skewness and kurtosis.[28] Patients with a history of falls were defined as those 19 
who reported at least one fall during the past year; patients without a history of falls were 20 
defined as those who reported no falls during the past year. Participants’ characteristics 21 
were compared between i) those with and without a history of falls and ii) those included 22 
in the reliability analysis and the remaining sample, using independent t-tests for normally 23 
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distributed data, Mann-Whitney U-tests for non-normally distributed and Chi-square tests 1 
for categorical data. 2 
Reliability 3 
Test-retest reliability was analyzed in a subsample of the first consecutive 31 participants. 4 
This sample size was determined according to the study from Bonnet,[29] which has 5 
established that a minimum of 21 individuals were necessary to estimate an ICC of 0.9 6 
with a 95% confidence interval width of 0.230 (α=0.05 and k=2). As interventions with 7 
patients with chronic kidney disease at various stages have considerable dropouts,[30] a 8 
40% attrition rate was estimated, yielding a sample of 31 participants. 9 
Test-retest reliability was computed using the scores from the same physiotherapist in 10 
sessions 1 and 2. For relative reliability, the ICC equation (2,1) was used as it was 11 
intended to generalize the present results to a variety of raters[31]. ICC was interpreted 12 
as excellent (>0.75), moderate to good (0.4-0.75) or poor (<0.4).[32] Agreement was 13 
explored with the Bland and Altman method and standard error of measurement (SEM). 14 
The Bland and Altman method was used for visual judgement of how well the 15 
measurements between sessions agreed.[33] 16 
The SEM indicates the extent to which a score varies on repeated measurements. It 17 
provides a value for measurement error in the same units as the measurement itself and 18 
thus, is easier to use in clinical practice.[34] It was calculated using equation 1: 19 
𝑆𝐸𝑀 = 𝑆𝐷 √(1 − 𝐼𝐶𝐶) (1) 
where SD is the standard deviation of the scores obtained from all individuals and ICC is 
20 
the test-retest reliability coefficient. 
21 
Minimal Detectable Change 22 
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The MDC at the 95% level of confidence (MDC95), is also reported in the same units as 1 
the measurement itself and represents the smallest change that can be interpreted as a real 2 
difference. It was calculated as follows (equation 2): 3 
𝑀𝐷𝐶95 = 𝑆𝐸𝑀 × 1.96 × √2 (2) 
The MDC was also expressed as a percentage (MDC%), defined as (equation 3): 4 
𝑀𝐷𝐶% = (𝑀𝐷𝐶95 𝑚𝑒𝑎𝑛) × 100⁄  (3) 
where mean is the mean of the scores obtained in the 2 testing sessions. The MDC% is 5 
independent of the units of measurement and facilitates the comparison of the random 6 
measurement error among different measures.[35] A MDC% below 30% is considered 7 
acceptable.[36] 8 
Validity 9 
Spearman’s correlation coefficient (rho) was used to examine the relationship among 10 
balance tests (concurrent validity) and between each balance test and the Activities-11 
specific Balance Confidence scale (convergent validity). 12 
All statistical analyses were performed using IBM SPSS Statistics version 20.0 (IBM 13 
Corporation, Armonk, NY, USA) and plots created using GraphPad Prism version 5.01 14 
(GraphPad Software, Inc., La Jolla, CA, USA). The level of significance was set at 0.05. 15 
 16 
Results 
17 
Participants 
18 
A total of 131 patients were screened and 82 were eligible. Two participants refused to 
19 
participate and 6 did not complete the assessment. Therefore, 74 participants were 
20 
included. Participants had a mean age of 63.9±15.1 years old and were mainly male 
21 
(n=49; 66.2%). Twenty-eight (37.8%) participants had history of falls. Twelve 
22 
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participants used walking aids, eleven used a cane and one used a walker. Participants’ 
1 
characteristics and balance scores are presented in table 1. All balance tests were able to 
2 
significantly differentiate between participants among age ranges (Table 2). 
3 
(table 1) 
4 
 (table 2) 
5 
Validity 
6 
All balance tests were strongly correlated with each other, with rho ranging from 0.89 to 7 
0.92 (p<0.001). The Activities-specific Balance Confidence scale was significantly 8 
correlated with the BESTest (rho=0.59), Mini-BESTest (rho=0.49) and the Brief-9 
BESTest (rho=0.5) (figure 1). 10 
(figure 1) 11 
Test-retest reliability 
12 
The characteristics of participants included in the reliability analysis (n=31) were not 
13 
significantly different from remaining participants. Table 2 presents the relative test-retest 
14 
reliability and the agreement of the BESTest, Mini-BESTest and the Brief-BESTest. 
15 
Excellent test-retest reliability was observed. Good test-retest agreement was verified for 
16 
all balance tests, with mean differences close to zero (table 3 and figure 2). 
17 
(table 3 and figure 2) 18 
Minimal detectable change 
19 
The MDC95 was 10.8 (SEM=3.9; MDC%=13.5%), 5.3 (SEM=1.9; MDC%=23.7%) and 
20 
5.6 (SEM=2; MDC%=34%) for the BESTest, Mini-BESTest and the Brief-BESTest, 
21 
respectively. 
22 
 
23 
Discussion 24 
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To our knowledge, this is the first study to investigate the validity, test-retest reliability 
1 
and minimal detectable change of the BESTest, Mini-BESTest and the Brief-BESTest in 
2 
patients with ESRD. The three tests are valid and reliable to assess balance in patients 
3 
with ESRD. The preliminary MDC found for these balance tests can be used by clinicians 
4 
to identify a true change in balance in patients with ESRD. 
5 
In this study, 37.8% of patients reported at least one fall in the previous 12 months. This 
6 
result is in line with previous research.[5, 6] In healthy older adults slightly lower 
7 
prevalences have been described (12.1%-33%).[27, 37, 38] In addition, patients with 
8 
history of falls were older than those without history of falls and had worse performance 
9 
in balance tests. It is known that older adults frequently present reduced skeletal muscle 
10 
strength, gait speed and physical activity levels [39]. These impairments may have also 
11 
contributed to the balance deficits found in patients with ESRD. This finding highlights 
12 
the need of screening for balance impairments in the comprehensive assessment of 
13 
patients with ESRD, particularly in those with more advanced age.  
14 
The BESTest, Mini-BESTest, and Brief-BESTest have shown to be valid in a variety of 
15 
clinical populations.[10, 18, 26, 40] In patients with ESRD, the three balance tests were 
16 
also significantly associated with each other and with the Activities-specific Balance 
17 
Confidence scale, demonstrating good concurrent and convergent validity. 
18 
Excellent results were found for test-retest reliability of the balance tests (ICC=0.84-
19 
0.94). Similar results have been found in reliability studies conducted in other 
20 
populations, such as Parkinson´s disease (ICC=0.88-0.90),[13] older cancer survivors 
21 
(ICC=0.90-0.94),[10] chronic obstructive pulmonary disease (ICC=0.82-0.87)[15] and 
22 
stroke (ICC=0.97).[26] Regarding agreement, results were also encouraging since 
23 
balance tests showed good agreement, with no systematic bias. Thus, it seems that 
24 
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clinicians can be confident in using these three balance tests to assess balance 
1 
impairments in patients with ESRD. 
2 
In this study, preliminary MDC95 values for BESTest, Mini-BESTest and Brief-BESTest 3 
were determined, which will be useful for clinicians working with patients with ESRD in 4 
assessing whether an intervention (e.g., rehabilitation program) has caused any real 5 
change in balance. However, MDCs were slightly higher than those established in other 6 
populations: BESTest (10.8 vs. range 6.2-9[10, 15, 41]), Mini-BESTest (5.3 vs. range 7 
2.4-3.8[10, 15, 18, 41]) and Brief-BESTest (5.6 vs. range 2.6-4.9[10, 15, 41]). These 8 
differences may be explained by the specificities of each population. But may also be 9 
related with the samples used. In the present study, participants’ mean age was 63.9 years 10 
old, with large age range 30-95. In the reported studies patients were somewhat older 11 
(mean ages between 66 and 76 years old [10, 15, 18, 27, 41]). It should be also noted that 12 
the MDC% of the Brief-BESTest was slightly higher (34%) than the value considered 13 
acceptable (i.e., <30%). However, this MDC% was obtained from one single performance 14 
at each session. Future studies should determine the MDC95 and MDC% from the average 15 
of two performances at each session. This procedure may reduce the magnitude of 16 
measurement error and consequently achieve lower values for the MDC95 and MDC%. 17 
This has been observed in tests for functional balance assessment, such as the Timed Up 18 
and Go test.[42] 19 
There are limitations in the present study that need to be acknowledged. First, the small 20 
sample size. Yet, the number of patients included is within the range (28 to 122) used in 21 
previous research assessing the clinimetric properties of the BESTest, Mini-BESTest or 22 
of the Brief-BESTest.[10, 18, 27, 41] Second, the sample was mainly composed of 23 
patients aged 60 or over (>70%), so generalization of findings are hindered to the younger 24 
14 
 
population of patients with ESRD. Future studies may replicate the study in larger 1 
samples of younger patients and report results per age ranges. Third, patients were 2 
classified as having or not having a history of falls based on their self-report hence, some 3 
degree of bias in their responses might have been present. Finally, the Mini-BESTest (14 4 
tasks) and Brief-BESTest (6 tasks) scores were derived from the patients’ performance 5 
on BESTest (36 tasks). The length of the BESTest may have produced a certain degree 6 
of fatigue. Thus, it might be thought that the scores of the BESTest shortened versions 7 
could be slightly different if performed independently from the BESTest. However, in 8 
order to address this concern, participants were given frequent resting breaks during the 9 
balance assessment. To clarify this, future studies should assess the validity, test-retest 10 
reliability and minimal detectable change of the Mini-BESTest and of the Brief-BESTest 11 
when performed separately from the BESTest. 12 
The BESTest, Mini-BESTest, and the Brief-BESTest are valid and reliable to 
13 
comprehensively assess balance in patients with ESRD. Nevertheless, based on the 
14 
minimal detectable changes, Balance Evaluation Systems Test and Mini-Balance 
15 
Evaluation Systems Test may be the most recommended; and the selection of one of them 
16 
may be based on time and equipment availability. 
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Table 1 - Participants’ characteristics (n=74). 
1 
Note: values show mean (SD) unless otherwise indicated. Abbreviations: BESTest, 2 
Balance Evaluation Systems Test; BMI, body mass index; IQR, interquartile range; M, 3 
median. 4 
 5 
 6 
 7 
 8 
 9 
 10 
Characteristics Total  
(n=74) 
Without 
history 
of falls (n=46) 
With history  
of falls (n=28) 
p-value 
Age (years) 63.9 (15.1) 61 (15.8) 68.8 (12.8) 0.029* 
Male, n(%) 49 (66.2) 32 (69.6) 17 (60.7) 0.298 
BMI (Kg/m2) 25.1 (4.3) 25.8 (4.7) 24.1 (3.2) 0.068 
Walking aid, n(%) 12 (16.2) 5(17.9) 7(15.2) 0.765 
Comorbidities, 
M[IQR] 
1 [0, 2] 1 [0, 2] 2 [0, 2.75] 0.403 
Activities-specific 
Balance Confidence  
scale 
64 (26.2) 69.5 (24.8) 55.4 (26.6) 0.034* 
BESTest 77.9 (17.3) 82 (15.6) 71.4 (18.1) 0.013* 
Mini-BESTest 21.7 (6) 22.8 (5.4) 20 (6.5) 0.061 
Brief-BESTest 14.9 (6.4) 16.6 (6.3) 12.1 (5.8) 0.003* 
23 
 
Table 2 – Balance tests scores per age ranges (n=74). 
1 
Note: values show mean (SD). Abbreviations: BESTest, Balance Evaluation Systems 2 
Test. 3 
  4 
Characteristics 30-49 yrs  
(n=16) 
50-69 yrs 
(n=27) 
>70 yrs  
(n=31) 
p-value 
BESTest 93.5 (6.6) 76.1 (18.8) 70.8 (14.5) <0.001 
Mini-BESTest 26.2 (1.8) 21.4 (6.4) 19.6 (5.9) 0.001 
Brief-BESTest 21.5 (2.8) 14.7 (5.6) 11.5 (5.8) <0.001 
24 
 
Table 3 - Test-retest reliability of the Balance Evaluation Systems Test (BESTest), Mini-1 
BESTest and the Brief-BESTest (n=31). 2 
Balance test 
Relative reliability  Agreement 
ICC2,1 95% CI  
Mean difference 
(SD) 95% LA 
BESTest 0.94 0.87→0.97  -0.7 (5.9) -12.3→10.8 
Mini-BESTest 0.84 0.70→0.92  -0.4 (2.9) -6→5.3 
Brief-BESTest 0.84 0.69→0.92  0.2 (3) -5.7→6.1 
Note: The ICC equations used were the ICC2,1. Abbreviations: 95% CI, 95% confidence 3 
intervals; ICC, Intraclass Correlation Coefficient; SD, standard deviation; 95% LA, 95% 4 
limits of agreement. 5 
  6 
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Figures 1 
Figure 1 - Scatterplots showing the relationship between the Activities-specific Balance 2 
Confidence (ABC) scale and (A) the Balance Evaluation Systems Test (BESTest), (B) 3 
the Mini-BESTest and (C) the Brief-BESTest (n=74). 4 
 5 
Figure 2 - Bland and Altman plots of the (A) Balance Evaluation Systems Test (BESTest), 6 
(B) Mini-BESTest and (C) Brief-BESTest between two sessions (n=31). The bold line 7 
represents the mean difference between sessions 1 and 2 and the dotted lines the 95% 8 
limits of agreement.  9 
 10 
